Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline

Wolters Kluwer launches UpToDate Expert AI to deliver trusted GenAI clinical decision support

Abbott announces quarterly common dividend

CVS Health declares unchanged quarterly dividend

ALK partners with GenSci to expand allergy immunotherapy market in China

Curatis secures Swiss distribution deal with Phoenix Labs

Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025

Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation

European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo

Essa Pharma clarifies Nasdaq due bill trading period for cash distribution

Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli

Heron Therapeutics announces tax benefits preservation plan adoption

Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return

BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation

GSK to receive USD370m and future royalties in CureVac/BioNTech settlement